Sunitinib for advanced pancreatic neuroendocrine tumors.
about
Evaluation of expression and function of vascular endothelial growth factor receptor 2, platelet derived growth factor receptors-alpha and -beta, KIT, and RET in canine apocrine gland anal sac adenocarcinoma and thyroid carcinomaMicroRNA modulation combined with sunitinib as a novel therapeutic strategy for pancreatic cancer.
P2860
Sunitinib for advanced pancreatic neuroendocrine tumors.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Sunitinib for advanced pancreatic neuroendocrine tumors.
@en
Sunitinib for advanced pancreatic neuroendocrine tumors.
@nl
type
label
Sunitinib for advanced pancreatic neuroendocrine tumors.
@en
Sunitinib for advanced pancreatic neuroendocrine tumors.
@nl
prefLabel
Sunitinib for advanced pancreatic neuroendocrine tumors.
@en
Sunitinib for advanced pancreatic neuroendocrine tumors.
@nl
P2860
P356
P1476
Sunitinib for advanced pancreatic neuroendocrine tumors
@en
P2093
Richard A Hubner
P2860
P304
P356
10.1586/ERA.11.171
P577
2011-12-01T00:00:00Z